Please provide your email address to receive an email when new articles are posted on . A subcutaneous implantable cardioverter defibrillator was noninferior to a transvenous ICD regarding major ...

In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...

Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...

SAN FRANCISCO, CA—The subcutaneous implantable cardioverter-defibrillator (S-ICD; Boston Scientific) prevents most of the major lead-related complications seen with a transvenous system, the ATLAS ...

An innovative surgical technique for patients with severe, treatment-resistant OCD has been tried for the first time in ...

Stockholm, Sweden - Early testing of an implantable cardioverter-defibrillator (ICD) featuring a totally subcutaneous lead system suggests the device can terminate ventricular tachyarrhythmias using ...

BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...

The Cleveland Clinic announced their team successfully implanted the world's first leadless pacemaker defibrillator system in two patients. Pacemakers provide electrical stimulation to regulate a ...

Boston Scientific's Emblem S-ICD, the next generation subcutaneous ICD product, is a novel technology that removes what many believe is the weakest link in implantable cardioverter defibrillators - ...

Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a study published in the journal ...

Cleveland Clinic doctors were the first in the world to successfully implant leadless pacemaker defibrillator systems in two patients as part of a global clinical trial sponsored by Boston Scientific, ...